Lessons learned from FDA’s current process and proposed alternative review strategies.
Jonathan S. Helfgott, MS
Advertisement
Faculty, Program Coordinator, Senior Lecturer, MS in Regulatory Science & Food Safety Regulation Programs, Johns Hopkins University
Articles by Jonathan S. Helfgott, MS
A probability sampling assessment by FDA takes a look at compliance in the medical device world.
Advertisement
Latest Updated Articles
Medical Device CompliancePublished: June 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
